Graeme Young

2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections

Fabio Garofolo, Mario L. Rocci, Isabelle Dumont et al. · Bioanalysis · 2011 · 93 citations

Pharmacy, Chemistry, Pharmaceutical Analysis +15

A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts

R. Colin Garner, James Barker, C Flavell et al. · Journal of Pharmaceutical and Biomedical Analysis · 2000 · 64 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +15

Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique

Graeme Young, William Ellis, John Ayrton et al. · Xenobiotica · 2001 · 59 citations

Natural Sciences, Chemistry, Pharmacology +13

Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study

Anthony Cahn, Simon T. Hodgson, Robert C. Wilson et al. · BMC Pharmacology and Toxicology · 2013 · 54 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches

Claire Beaumont, Graeme Young, Tom M. Cavalier et al. · British Journal of Clinical Pharmacology · 2014 · 53 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11